Anlongmed Fund

About

Anlongmed Fund is focused on early-stage investments in the life sciences and healthcare-related fields.

Beijing,Beijing,China
http://anlongmed.com/en/

Highlights

Details

Industries: Financial Services
Operating Status: Active
Legal Name: Anlong Investment Management Ltd
Also Known As: 安龙基金
Investor Type: Venture Capital

AnlongMed is a venture capital fund focuses on early stage life science and healthcare sectors. It is managed by a team led by Dr. Adam Zhao Chunlin, a veteran in life science with 30 years of experience, along with professionals with MNC, R&D, clinical, entrepreneurial and investment experience in both U.S. and China. The fund is anchored by Chinese Academy of Sciences. With extensive experience and connections from Chinese Academy of Sciences, Tsinghua University, Peking Union Medical College, and Bayhelix Group, AnlongMed strives to help entrepreneurs to start a venture in life science and healthcare in China. The fund has invested 22 firms from its first phase， including Netvation, a joint initiative toward new drug development between Chinese Academy of Science and Pfizer, Inc, 4 companies founded together with entrepreneurs across life science, biopharmaceutical, medical devices, and healthcare services.

Investments

Number of Investments

Number of Lead Investments

9

3

Anlongmed Fund has made 9 investments. Their most recent investment was on Jan 20, 2021, when Skynor Medical raised 0.

Date Company Name	Round	Money Raised	Industry	Lead Investor
Jan 20, 2021 Skynor Medical	Series B	—	Health Care	—
Jun 23, 2020 Sophonix	Series B	¥100M	Biotechnology	—
Aug 1, 2019 Zhenzhun Biotech	Series A	—	Biotechnology	Yes
Jun 4, 2018 Laekna Therapeutics	Series A	$18.50M	Biotechnology	—
May 8, 2018 Jun Hui Biotech	Seed	—	Health Care	Yes